Adaptive immune response to therapy in hmgcr autoantibody myopathy.

about

Adaptive immune response to therapy in hmgcr autoantibody myopathy.

Item

http://www.wikidata.org/entity/Q43079949

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Adaptive immune response to therapy in hmgcr autoantibody myopathy.

@en

Adaptive immune response to therapy in hmgcr autoantibody myopathy.

@nl

type

Item

label

Adaptive immune response to therapy in hmgcr autoantibody myopathy.

@en

Adaptive immune response to therapy in hmgcr autoantibody myopathy.

@nl

prefLabel

Adaptive immune response to therapy in hmgcr autoantibody myopathy.

@en

Adaptive immune response to therapy in hmgcr autoantibody myopathy.

@nl

P1476

Adaptive immune response to therapy in hmgcr autoantibody myopathy.

@en

P2093

Jeffrey T Guptill

http://www.w3.org/2001/XMLSchema#string

John S Yi

http://www.w3.org/2001/XMLSchema#string

Kent J Weinhold

http://www.w3.org/2001/XMLSchema#string

Melissa A Russo

http://www.w3.org/2001/XMLSchema#string

P2860

Paths to stemness: building the ultimate antitumour T cell.

Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.

Characterization of B cells in muscle-specific kinase antibody myasthenia gravis.

Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation.

Abnormalities of B cell subsets in patients with systemic lupus erythematosus.

P304

313-317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MUS.24947

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283207249

http://www.w3.org/2001/XMLSchema#string

P698

26492512

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody

P932

4718836

http://www.w3.org/2001/XMLSchema#string